SlideShare a Scribd company logo
1 of 28
Download to read offline
H1 and H2 antagonist
By- Aniket kumar
M. Pharm 1st semester
(pharmaceutical chemistry)
CONTENTS
HISTAMINE
ANTIHISTAMINE
RECEPTOR OF ANTIHISTAMINE
CLASSIFICATION OF H1 ANTIHISTAMINE
MOA H1 ANTAGONIST
SAR OF H1 ANTAGONIST
H2 ANTAGONIST
MOA H2 ANTAGONIST
SAR OF H2 ANTAGONIST
Histamine
• Histamine is a chemical messenger which are synthesized in the mast cell.
• Histamine is present in practically all tissues , with significant amounts in
the lungs, skin, blood vessels and GI tract.
• Generally histamine are found in the animal tissue , venom of insects
bacteria and plant.
• Histamine a substance that play a major role in many allergic reaction ,
dilating blood vessel and making the vessel walls abnormally permeable.
• Histamine is a signalling molecule ,sending message b/w cells. It tells
stomach cells to make stomach acid and it helps our brain
• English scientists George Barger and Henry H. Dale first isolated histamine
from the plant fungus ergot in 1910 and in 1911 they isolated the substance
from animal tissues.
• Histamine [2 (imidazole -4-yl) ethylamine] which is biosynthesized by
decarboxylation of the basic amino acid histidine ,is found all organ and tissue
of the human body.
• It is formed by the decarboxylation (the removal of a carboxyl group) of the
amino acid histidine.
ANTIHISTAMINE
• These are the drugs which diminish or antagonize the action of
endogenously released histamine in the body .
• Antihistamines are generally antagonist of H1 receptor.
• These are used for the treatment of allergy and pruritis
• Antagonist of H2 receptor are use to inhibit gastric acid secretion (treatment
of peptic ulcer).
• The human body contains histaminic receptor and are divided into three
different types upon their action
1. H1- receptor
2. H2- receptor
3. H3- receptor
Name of receptor Place where it present in our
body
Antagonist
H1-receprtor
Smooth muscles ,intestine , bronchi , blood
vessels
Diphenhydramine
mepyramine
H2-receptor Gastric parietal cells Cimetidine
ranitidine
H3 –receptor Neuron , CNS cells Thioperamide
RECEPTORS OF ANTIHISTAMINES
H1 RECEPTOR ANTAGONIST
• In the year 1933 the first drug Piperoxan invented Bovet & Furnease. This
drug can protect the animal from bronchial spasm. The drug is the initiation
for the discovery of H1 receptor antagonist.
• In the year 1942 , Halpen researched and reported about 24 derivative of
ethylene diamine in which Phenbenzamine was found to be most potent and
is used the first H1 antagonist used clinically.
• H1 antagonists act by competitively inhibiting the effects of histamine at H1
receptor
Mechanism of action of H1 antagonist
H1 antagonist
• CLASSIFICATION OF H1 ANTAGONIST
H1 ANTAGONIST
FIRST GENERATION
1. AMINO ALKYL ETHERS - DIPHENHYDRAMINE
2. ETHYLENEDIAMINE – TRIPELENNAMINE
3.CYCLIC BASIC CHAIN DERIVATIVE-
CHLORCYCLIZINE
4.PROPYL AMINE DERIVATIVE- PHENIRAMINE,
TRIOLIDINE
5.PHENOTHIAZINE DERIVATIVE- PROMETHAZINE
6. DIBENZO CYCLOHEPTADINE- AZATIDINE
7. MISSCELLANEOUS - ANTAZOLINE
SECOND GENERATION
1.PIPERAZINE-
CETRIZINE/LEVOCETIRIZINE
2.PIPERIDINES- FEXOFENADINE ,
LORATADINE/ DESLORATADINE
SAR –H1 RECEPTOR ANTAGONISTS
1. Aryl groups
The diaryl substitution is essential for significant H1 affinity. It is present both in first
generation and second generation antihistamines. The optimal antihistaminic activity
depends on the co-planarity of two aryl substitutions.
Active aryl substitutions are as follows:
Ar1 is phenyl and hetero aryl group like 2-pyridyl Ar1 -Aryl or aryl methyl group
2. Nature of X
Antihistamines with X = carbon (pheniramine series) represents the stereo selective receptor
binding to the receptors due to its chirality.
The active substitutions of X are as follows:
Where X = oxygen (amino alkyl ether analogue)
X = nitrogen (ethylene-diamine derivative)
X = carbon (mono amino propyl analogue)
3. The Alkyl Chain
Most of the antihistamines have ethylene chain, and branching of this chain results in a less
active compound.
4. Terminal nitrogen atom:
The terminal N-atom should be a 3° amine for maximum activity. The terminal nitrogen
may be a part of heterocyclic ring. For example, antazoline and chlorcyclizine, retains high
antihistaminic activity. The amino moiety deserves the protonation on interaction with H1
receptor due to the basicity with pka 8.5-10
chlorcyclizine
1st Generation Antihistaminic agents
AMINO ALKYL ETHERS
DIPHENHYDRAMINE
DOXYLAMINE
USES- Antiemetic,
Antihistamine, Antitussive
,smooth , Muscle Relaxant ,
sedative Action
USES- Cough ,cold ,
allergic conjuctivites
ETHYLENDIAMINE DERIVATIVE
Tripelennamine
USES- Allergic rhinitis ,
Conjunctivitis, Angioedema
Uses-Urticaria, conjunctivitis ,hay fever ,antiemetics
CYCLIC BASIC CHAIN DERIVATIVE
Cyclizine Chlorcyclizine
PROYLAMINE ANALOGS
Triprolidine
• It is most potent antihistaminic
agents.
• The activity is mainly due to
geometric isomer in which the
pyrrolidino - methyl group is
trans to the 2pyridyl group.
• E isomer showed more activity
then Z isomer.
PHENOTHIAZINE DERIVATIVE-
PROMETHAZINE
• It is the most potent
antihistaminic agents
• Use in perennial and
seasonal allergic rhinitis,
allergic conjunctivitis
USES-
2nd Generation Antihistaminic agents
Fexofenatidine
• Used in the
treatment of
allergy
symptoms, such
as hay fever ,
watery eyes,
runny nose,
itching eyes
,sneezing, and
urticaria
• Sedative
peripheral h1
blocker
Loratidine
It is long acting ,non sedative tricyclic
antihistaminic drug.
Used to treat sneezing , runny nose,
watery eye, skin rash , itching, and
cold or allergy symptoms
SYNTHESIS OF CETIRIZINE
H2 Antagonist
• The histamine H2 receptor antagonist act on H2 receptor in the stomach
blood vessel and other sites.
• They are competitive antagonist of histamine and are fully reversible
• H2 antagonist are group of medicines that reduce the amount of acid
produced by the cell in the lining of the stomach are commonly called
H2 blocker
• These products have been approved for the relief of “heartburn”
associated with acid indigestion ,and sour stomach.
• Drugs – cimetidine, ranitidine, famotidine.
H2 antagonist
MECHANISM OF ACTION H2 ANTAGONIST
SAR OF H2 ANTAGONIST
• The H2 receptor antagonist were the result of the intentional
modification of the histamine structure and deliberate search for a
chemically related substance that would act as a competitive inhibitor.
Imidazole ring is not the only required ring fir competitive antagonism of
histamine H2 receptor
• Other Heterocyclic ring present like Cimetidine ( Imidazole) ,ranitidine
(furan), famotidine (Thiazole) etc ,that enhance the potency and
selectivity of H2 receptor antagonist can be used.
• The ring is terminal nitrogen should be separated by four carbon atom
for optimum antagonistic activity.
• The terminal nitrogen group should be polar ,non basic substituent for
maximal antagonistic activity.
H2 receptor antagonist
Cimetidine
Famotidine
Cimetidine is a stomach acid reflux that is
used to treat and prevent certain types of
stomach ulcer
Used to treat gastroesophageal reflux
disease (GERD) and heart burn.
Famotidine is used to treat and
prevent ulcers in the stomach and
intestine.
It is used to trat Zollinger- Elison
syndrome
RANITIDINE
USES-
• In the treatment and prevention of stomach and intestinal ulcers
• In the treatment of gastritis (stomach inflammation) caused by kidney failure
• Used is in the management of acid reflux disease to reduce injury to the oesophagus
( food tube) caused by the upward movement of stomach acid.
REFFERENCES
• Eliezer J. Barreiro, Arthur E. Kümmerle, and Carlos A. M. Frag . The
Methylation Effect in Medicinal Chemistry. Chemical Reviews 2011,
111 (9) , 5215-5246
• . A. M. Mocking, R. Bosma , S. N. Rahman, E. W. E. Verweij, Daniel A.
McNaught-Flores, Henry F. Vischer , Rob Leurs . Molecular Aspects of
Histamine Receptors.
• Patrick Igel , Stefan Dove, Armin Buschauer . Histamine H4 receptor
agonists. Bioorganic & Medicinal Chemistry Letters 2010, 20 (24) ,
7191-7199.
H1 and H2 antagonist Medicinal Chemistry.pptx

More Related Content

What's hot

Enantio selectivity in pharmacokinetics
Enantio selectivity in pharmacokineticsEnantio selectivity in pharmacokinetics
Enantio selectivity in pharmacokineticsROHIT PAL
 
Rational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptxRational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptxRashuRaju
 
Role of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agentRole of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agentKaranvir Rajput
 
Validation & Diversity of drug targets
Validation & Diversity of drug targetsValidation & Diversity of drug targets
Validation & Diversity of drug targetsSnigdhaBharadwaaj
 
Chemistry of prostaglandins, leukotrienes and thromboxanes
Chemistry of prostaglandins, leukotrienes and thromboxanesChemistry of prostaglandins, leukotrienes and thromboxanes
Chemistry of prostaglandins, leukotrienes and thromboxanesAbhimanyu Awasthi
 
ANALOG DESIGN.pdf
ANALOG DESIGN.pdfANALOG DESIGN.pdf
ANALOG DESIGN.pdfShivalingMP
 
TRAUBE PURINE SYNTHESIS.pptx
TRAUBE PURINE SYNTHESIS.pptxTRAUBE PURINE SYNTHESIS.pptx
TRAUBE PURINE SYNTHESIS.pptxPratikKapse8
 
Biological drug targets.pptx
Biological drug targets.pptxBiological drug targets.pptx
Biological drug targets.pptxPurushothamKN1
 
Reactions of heterocyclic chemistry
 Reactions of heterocyclic chemistry Reactions of heterocyclic chemistry
Reactions of heterocyclic chemistrysuraj wanjari
 
Strategies to synthesize 5 & 6 membered heterocyclic.pptx
Strategies to synthesize 5 & 6 membered heterocyclic.pptxStrategies to synthesize 5 & 6 membered heterocyclic.pptx
Strategies to synthesize 5 & 6 membered heterocyclic.pptxPrabhjotKaur934413
 
synthetic Reagents and its application Diazomethane
synthetic Reagents and its application      Diazomethanesynthetic Reagents and its application      Diazomethane
synthetic Reagents and its application DiazomethaneFirujAhmed2
 
Combating Drug resistance
Combating Drug resistanceCombating Drug resistance
Combating Drug resistanceHarendra Bisht
 

What's hot (20)

Enantio selectivity in pharmacokinetics
Enantio selectivity in pharmacokineticsEnantio selectivity in pharmacokinetics
Enantio selectivity in pharmacokinetics
 
synthon approach
 synthon approach  synthon approach
synthon approach
 
Rational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptxRational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptx
 
named reaction.pptx
named reaction.pptxnamed reaction.pptx
named reaction.pptx
 
Role of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agentRole of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agent
 
Reaction of synthetic importance.ppt
Reaction of synthetic importance.pptReaction of synthetic importance.ppt
Reaction of synthetic importance.ppt
 
Validation & Diversity of drug targets
Validation & Diversity of drug targetsValidation & Diversity of drug targets
Validation & Diversity of drug targets
 
Chemistry of prostaglandins, leukotrienes and thromboxanes
Chemistry of prostaglandins, leukotrienes and thromboxanesChemistry of prostaglandins, leukotrienes and thromboxanes
Chemistry of prostaglandins, leukotrienes and thromboxanes
 
Drugs Acting on CNS-Antipsychotics
Drugs Acting on CNS-AntipsychoticsDrugs Acting on CNS-Antipsychotics
Drugs Acting on CNS-Antipsychotics
 
ANALOG DESIGN.pdf
ANALOG DESIGN.pdfANALOG DESIGN.pdf
ANALOG DESIGN.pdf
 
TRAUBE PURINE SYNTHESIS.pptx
TRAUBE PURINE SYNTHESIS.pptxTRAUBE PURINE SYNTHESIS.pptx
TRAUBE PURINE SYNTHESIS.pptx
 
peptidomimetics.pdf
peptidomimetics.pdfpeptidomimetics.pdf
peptidomimetics.pdf
 
Wittig reagent
Wittig reagentWittig reagent
Wittig reagent
 
Biological drug targets.pptx
Biological drug targets.pptxBiological drug targets.pptx
Biological drug targets.pptx
 
Reactions of heterocyclic chemistry
 Reactions of heterocyclic chemistry Reactions of heterocyclic chemistry
Reactions of heterocyclic chemistry
 
Strategies to synthesize 5 & 6 membered heterocyclic.pptx
Strategies to synthesize 5 & 6 membered heterocyclic.pptxStrategies to synthesize 5 & 6 membered heterocyclic.pptx
Strategies to synthesize 5 & 6 membered heterocyclic.pptx
 
MITSUNUBU REACTION.pptx
MITSUNUBU REACTION.pptxMITSUNUBU REACTION.pptx
MITSUNUBU REACTION.pptx
 
Protecting groups
Protecting groupsProtecting groups
Protecting groups
 
synthetic Reagents and its application Diazomethane
synthetic Reagents and its application      Diazomethanesynthetic Reagents and its application      Diazomethane
synthetic Reagents and its application Diazomethane
 
Combating Drug resistance
Combating Drug resistanceCombating Drug resistance
Combating Drug resistance
 

Similar to H1 and H2 antagonist Medicinal Chemistry.pptx

Similar to H1 and H2 antagonist Medicinal Chemistry.pptx (20)

H1 & H2 receptor antagonist
H1 & H2 receptor antagonistH1 & H2 receptor antagonist
H1 & H2 receptor antagonist
 
Anti histamine drug
Anti  histamine drug Anti  histamine drug
Anti histamine drug
 
Anti histamine
Anti  histamineAnti  histamine
Anti histamine
 
Antihistaminc agents
Antihistaminc agentsAntihistaminc agents
Antihistaminc agents
 
Autacoids
AutacoidsAutacoids
Autacoids
 
H1andh2receptors 170911151157 amit patidar
H1andh2receptors 170911151157 amit patidarH1andh2receptors 170911151157 amit patidar
H1andh2receptors 170911151157 amit patidar
 
H1and h2 receptors
H1and h2 receptorsH1and h2 receptors
H1and h2 receptors
 
Antihistamine
Antihistamine Antihistamine
Antihistamine
 
Class antihistaminics
Class antihistaminicsClass antihistaminics
Class antihistaminics
 
H1 and H2.pptx
H1 and H2.pptxH1 and H2.pptx
H1 and H2.pptx
 
Antihistaminic Agents.pptx
Antihistaminic Agents.pptxAntihistaminic Agents.pptx
Antihistaminic Agents.pptx
 
Antihistamine 170718063056
Antihistamine 170718063056Antihistamine 170718063056
Antihistamine 170718063056
 
H1 & h2 receptor blockers
H1 &  h2 receptor blockersH1 &  h2 receptor blockers
H1 & h2 receptor blockers
 
Antihistamine
AntihistamineAntihistamine
Antihistamine
 
Antihistamin.ppt
Antihistamin.pptAntihistamin.ppt
Antihistamin.ppt
 
Histamin-Medicinal Chemistry MANIK
Histamin-Medicinal Chemistry MANIKHistamin-Medicinal Chemistry MANIK
Histamin-Medicinal Chemistry MANIK
 
Advanced Medicinal Chemistry: H1&H2 antagonists
Advanced Medicinal Chemistry: H1&H2 antagonistsAdvanced Medicinal Chemistry: H1&H2 antagonists
Advanced Medicinal Chemistry: H1&H2 antagonists
 
Antihistamines
Antihistamines Antihistamines
Antihistamines
 
Antihisminic agents
Antihisminic agentsAntihisminic agents
Antihisminic agents
 
histamine
histaminehistamine
histamine
 

Recently uploaded

COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxannathomasp01
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfSherif Taha
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the ClassroomPooky Knightsmith
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxJisc
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...Nguyen Thanh Tu Collection
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfDr Vijay Vishwakarma
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxDr. Sarita Anand
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Pooja Bhuva
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024Elizabeth Walsh
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxDr. Ravikiran H M Gowda
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxheathfieldcps1
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 

Recently uploaded (20)

COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 

H1 and H2 antagonist Medicinal Chemistry.pptx

  • 1. H1 and H2 antagonist By- Aniket kumar M. Pharm 1st semester (pharmaceutical chemistry)
  • 2. CONTENTS HISTAMINE ANTIHISTAMINE RECEPTOR OF ANTIHISTAMINE CLASSIFICATION OF H1 ANTIHISTAMINE MOA H1 ANTAGONIST SAR OF H1 ANTAGONIST H2 ANTAGONIST MOA H2 ANTAGONIST SAR OF H2 ANTAGONIST
  • 3. Histamine • Histamine is a chemical messenger which are synthesized in the mast cell. • Histamine is present in practically all tissues , with significant amounts in the lungs, skin, blood vessels and GI tract. • Generally histamine are found in the animal tissue , venom of insects bacteria and plant. • Histamine a substance that play a major role in many allergic reaction , dilating blood vessel and making the vessel walls abnormally permeable. • Histamine is a signalling molecule ,sending message b/w cells. It tells stomach cells to make stomach acid and it helps our brain
  • 4. • English scientists George Barger and Henry H. Dale first isolated histamine from the plant fungus ergot in 1910 and in 1911 they isolated the substance from animal tissues. • Histamine [2 (imidazole -4-yl) ethylamine] which is biosynthesized by decarboxylation of the basic amino acid histidine ,is found all organ and tissue of the human body. • It is formed by the decarboxylation (the removal of a carboxyl group) of the amino acid histidine.
  • 5. ANTIHISTAMINE • These are the drugs which diminish or antagonize the action of endogenously released histamine in the body . • Antihistamines are generally antagonist of H1 receptor. • These are used for the treatment of allergy and pruritis • Antagonist of H2 receptor are use to inhibit gastric acid secretion (treatment of peptic ulcer). • The human body contains histaminic receptor and are divided into three different types upon their action 1. H1- receptor 2. H2- receptor 3. H3- receptor
  • 6. Name of receptor Place where it present in our body Antagonist H1-receprtor Smooth muscles ,intestine , bronchi , blood vessels Diphenhydramine mepyramine H2-receptor Gastric parietal cells Cimetidine ranitidine H3 –receptor Neuron , CNS cells Thioperamide RECEPTORS OF ANTIHISTAMINES
  • 7. H1 RECEPTOR ANTAGONIST • In the year 1933 the first drug Piperoxan invented Bovet & Furnease. This drug can protect the animal from bronchial spasm. The drug is the initiation for the discovery of H1 receptor antagonist. • In the year 1942 , Halpen researched and reported about 24 derivative of ethylene diamine in which Phenbenzamine was found to be most potent and is used the first H1 antagonist used clinically. • H1 antagonists act by competitively inhibiting the effects of histamine at H1 receptor
  • 8.
  • 9. Mechanism of action of H1 antagonist H1 antagonist
  • 10. • CLASSIFICATION OF H1 ANTAGONIST H1 ANTAGONIST FIRST GENERATION 1. AMINO ALKYL ETHERS - DIPHENHYDRAMINE 2. ETHYLENEDIAMINE – TRIPELENNAMINE 3.CYCLIC BASIC CHAIN DERIVATIVE- CHLORCYCLIZINE 4.PROPYL AMINE DERIVATIVE- PHENIRAMINE, TRIOLIDINE 5.PHENOTHIAZINE DERIVATIVE- PROMETHAZINE 6. DIBENZO CYCLOHEPTADINE- AZATIDINE 7. MISSCELLANEOUS - ANTAZOLINE SECOND GENERATION 1.PIPERAZINE- CETRIZINE/LEVOCETIRIZINE 2.PIPERIDINES- FEXOFENADINE , LORATADINE/ DESLORATADINE
  • 11. SAR –H1 RECEPTOR ANTAGONISTS 1. Aryl groups The diaryl substitution is essential for significant H1 affinity. It is present both in first generation and second generation antihistamines. The optimal antihistaminic activity depends on the co-planarity of two aryl substitutions. Active aryl substitutions are as follows: Ar1 is phenyl and hetero aryl group like 2-pyridyl Ar1 -Aryl or aryl methyl group
  • 12. 2. Nature of X Antihistamines with X = carbon (pheniramine series) represents the stereo selective receptor binding to the receptors due to its chirality. The active substitutions of X are as follows: Where X = oxygen (amino alkyl ether analogue) X = nitrogen (ethylene-diamine derivative) X = carbon (mono amino propyl analogue) 3. The Alkyl Chain Most of the antihistamines have ethylene chain, and branching of this chain results in a less active compound.
  • 13. 4. Terminal nitrogen atom: The terminal N-atom should be a 3° amine for maximum activity. The terminal nitrogen may be a part of heterocyclic ring. For example, antazoline and chlorcyclizine, retains high antihistaminic activity. The amino moiety deserves the protonation on interaction with H1 receptor due to the basicity with pka 8.5-10 chlorcyclizine
  • 14. 1st Generation Antihistaminic agents AMINO ALKYL ETHERS DIPHENHYDRAMINE DOXYLAMINE USES- Antiemetic, Antihistamine, Antitussive ,smooth , Muscle Relaxant , sedative Action USES- Cough ,cold , allergic conjuctivites
  • 15. ETHYLENDIAMINE DERIVATIVE Tripelennamine USES- Allergic rhinitis , Conjunctivitis, Angioedema Uses-Urticaria, conjunctivitis ,hay fever ,antiemetics CYCLIC BASIC CHAIN DERIVATIVE Cyclizine Chlorcyclizine
  • 16. PROYLAMINE ANALOGS Triprolidine • It is most potent antihistaminic agents. • The activity is mainly due to geometric isomer in which the pyrrolidino - methyl group is trans to the 2pyridyl group. • E isomer showed more activity then Z isomer.
  • 17. PHENOTHIAZINE DERIVATIVE- PROMETHAZINE • It is the most potent antihistaminic agents • Use in perennial and seasonal allergic rhinitis, allergic conjunctivitis USES-
  • 18. 2nd Generation Antihistaminic agents Fexofenatidine • Used in the treatment of allergy symptoms, such as hay fever , watery eyes, runny nose, itching eyes ,sneezing, and urticaria • Sedative peripheral h1 blocker Loratidine It is long acting ,non sedative tricyclic antihistaminic drug. Used to treat sneezing , runny nose, watery eye, skin rash , itching, and cold or allergy symptoms
  • 20. H2 Antagonist • The histamine H2 receptor antagonist act on H2 receptor in the stomach blood vessel and other sites. • They are competitive antagonist of histamine and are fully reversible • H2 antagonist are group of medicines that reduce the amount of acid produced by the cell in the lining of the stomach are commonly called H2 blocker • These products have been approved for the relief of “heartburn” associated with acid indigestion ,and sour stomach. • Drugs – cimetidine, ranitidine, famotidine.
  • 21.
  • 22. H2 antagonist MECHANISM OF ACTION H2 ANTAGONIST
  • 23. SAR OF H2 ANTAGONIST • The H2 receptor antagonist were the result of the intentional modification of the histamine structure and deliberate search for a chemically related substance that would act as a competitive inhibitor. Imidazole ring is not the only required ring fir competitive antagonism of histamine H2 receptor
  • 24. • Other Heterocyclic ring present like Cimetidine ( Imidazole) ,ranitidine (furan), famotidine (Thiazole) etc ,that enhance the potency and selectivity of H2 receptor antagonist can be used. • The ring is terminal nitrogen should be separated by four carbon atom for optimum antagonistic activity. • The terminal nitrogen group should be polar ,non basic substituent for maximal antagonistic activity.
  • 25. H2 receptor antagonist Cimetidine Famotidine Cimetidine is a stomach acid reflux that is used to treat and prevent certain types of stomach ulcer Used to treat gastroesophageal reflux disease (GERD) and heart burn. Famotidine is used to treat and prevent ulcers in the stomach and intestine. It is used to trat Zollinger- Elison syndrome
  • 26. RANITIDINE USES- • In the treatment and prevention of stomach and intestinal ulcers • In the treatment of gastritis (stomach inflammation) caused by kidney failure • Used is in the management of acid reflux disease to reduce injury to the oesophagus ( food tube) caused by the upward movement of stomach acid.
  • 27. REFFERENCES • Eliezer J. Barreiro, Arthur E. Kümmerle, and Carlos A. M. Frag . The Methylation Effect in Medicinal Chemistry. Chemical Reviews 2011, 111 (9) , 5215-5246 • . A. M. Mocking, R. Bosma , S. N. Rahman, E. W. E. Verweij, Daniel A. McNaught-Flores, Henry F. Vischer , Rob Leurs . Molecular Aspects of Histamine Receptors. • Patrick Igel , Stefan Dove, Armin Buschauer . Histamine H4 receptor agonists. Bioorganic & Medicinal Chemistry Letters 2010, 20 (24) , 7191-7199.